Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA-PAI-1 and by enhancing their expression

被引:30
作者
Bajou, K
Lewalle, JM
Martinez, CR
Soria, C
Lu, H
Noël, A
Foidart, JM
机构
[1] Univ Liege, Lab Tumor & Dev Biol, B-4000 Liege, Belgium
[2] Hop St Louis, INSERM U353, Paris, France
关键词
HUVEC; MDA MB 231; MCF7; angiogenesis; serine protease;
D O I
10.1002/ijc.10487
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
During angiogenesis, endothelial cells use uPA and PAI-I to migrate and degrade the basement membrane surrounding capillary blood vessels. Invasive tumor cells produce a large amount of uPA that could bind uPAR present at the endothelial cell surface to facilitate their invasion. To verify this hypothesis, endothelial cells were incubated with conditioned medium (CM) from two breast cancer cell lines (MCF7 and MDA MB 231 cells). Within a short incubation period (30 min) with both CM, an increase of uPA, PAW and uPA-PAI-I complex was detected in endothelial cell layer as assessed by casein zymography, ELISA and uPA immunostaining. The extent of this enhancement was related to the levels of uPA secreted by tumor cells (high in MDA MB 231 cells and low in MCF7 cells). After 2 hr of incubation, the CM from both tumor cells upregulated uPA and PAI-I mRNA levels in endothelial cells in a time-dependent manner. The uPA increase in the cell layer could not be attributable to an increase of uPAR level. Only the CM from highly invasive MDA MB 231 cells increased the angiogenic morphotype of endothelial cells assessed in a collagen gel. A single addition of amino-terminal fragment of uPA (ATF) was able to abolish the angiogenic effect induced by MDA MB 231 cell CM. Our data demonstrate that the interactions occurring between breast tumor cells and endothelial cells can modulate tumor angiogenesis at least by two mechanisms: an increase of uPA and PAI-I cell surface-binding and of their expression by endothelial cells. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:501 / 506
页数:6
相关论文
共 36 条
  • [1] PLASMINOGEN-ACTIVATOR INHIBITORS - HORMONALLY REGULATED SERPINS
    ANDREASEN, PA
    GEORG, B
    LUND, LR
    RICCIO, A
    STACEY, SN
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1990, 68 (01) : 1 - 19
  • [2] Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
  • [3] 2-Z
  • [4] Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
    Bajou, K
    Noël, A
    Gerard, RD
    Masson, V
    Brunner, N
    Holst-Hansen, C
    Skobe, M
    Fusenig, NE
    Carmeliet, P
    Collen, D
    Foidart, JM
    [J]. NATURE MEDICINE, 1998, 4 (08) : 923 - 928
  • [5] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [6] PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER
    DANO, K
    ANDREASEN, PA
    GRONDAHLHANSEN, J
    KRISTENSEN, P
    NIELSEN, LS
    SKRIVER, L
    [J]. ADVANCES IN CANCER RESEARCH, 1985, 44 : 139 - 266
  • [7] ELYAZIDI I, 1995, ANTICANCER RES, V15, P783
  • [8] INDUCTION OF ANGIOGENESIS DURING THE TRANSITION FROM HYPERPLASIA TO NEOPLASIA
    FOLKMAN, J
    WATSON, K
    INGBER, D
    HANAHAN, D
    [J]. NATURE, 1989, 339 (6219) : 58 - 61
  • [9] WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT
    FOLKMAN, J
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01): : 4 - 6
  • [10] Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells
    Gualandris, A
    Conejo, TL
    Giunciuglio, D
    Albini, A
    Sabini, E
    Rusnati, M
    DellEra, P
    Presta, M
    [J]. MICROVASCULAR RESEARCH, 1997, 53 (03) : 254 - 260